Trending...
- EQT Joins the Oil & Gas Decarbonization Charter USA - English USA - English
- REA 'Peace of Mind on the Move' Study achieves Highly Commended recognition in the category Excellence in Coaching by ABP November 2023
- Lumena, A New Luxury Oceanfront Condominium Takes Flight on Florida's Space Coast
BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Olaplex Holdings, Inc. ("Olaplex" or the "Company") (NASDAQ: OLPX) common stock pursuant and/or traceable to the Company's September 2021 initial public offering (the "IPO"). Olaplex investors have until January 17, 2023 to file a lead plaintiff motion.
Investors suffering losses on their Olaplex investments are encouraged to contact the Law Offices of Howard G. Smith to discuss their legal rights in this class action at 888-638-4847 or by email to howardsmith@howardsmithlaw.com.
In September 2021 Olaplex conducted its IPO, selling 73.7 million shares of common stock at $21.00 per share.
On September 29, 2022, Piper Sandler downgraded the stock to Neutral based on work showing that "competition and misinformation pose growing risks to the company." On this news, Olaplex's stock price fell $1.33, or 12.2%, to close at $9.62 per share on September 29, 2022, thereby injuring investors.
More on The PennZone
Then, on October 18, 2022, Olaplex reduced its financial outlook for fiscal 2022, expecting net sales between $704 million and $711 million. The Company attributed the revised guidance to "a slowdown in sales momentum that it attributes to macro-economic pressures, increased competitive activity including discounting, and a moderation in new customer acquisition." Additionally, Olaplex announced that its Chief Operating Officer was stepping down from her post.
On this news, Olaplex's stock price fell $5.55, or 56.7%, to close at $4.24 per share on October 19, 2022, significantly below the IPO price.
The complaint filed in this class action alleges that Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company's business, operations, and prospects. Specifically, Defendants failed to disclose to investors that: (1) macroeconomic pressures and competition in the haircare market were more robust than the Company had represented to investors; (2) accordingly, the Company was unlikely to maintain its sales and revenue momentum; and (3) as a result, it was unlikely that the Company would be able to achieve the financial and operational growth projected in the Offering Documents; and (4) as a result, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis at all relevant times.
More on The PennZone
If you purchased Olaplex common stock, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Howard G. Smith, Esquire, of Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020, by telephone at (215) 638-4847, toll-free at (888) 638-4847, or by email to howardsmith@howardsmithlaw.com, or visit our website at www.howardsmithlaw.com.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
Contacts
Law Offices of Howard G. Smith
Howard G. Smith, Esquire
215-638-4847
888-638-4847
howardsmith@howardsmithlaw.com
www.howardsmithlaw.com
Investors suffering losses on their Olaplex investments are encouraged to contact the Law Offices of Howard G. Smith to discuss their legal rights in this class action at 888-638-4847 or by email to howardsmith@howardsmithlaw.com.
In September 2021 Olaplex conducted its IPO, selling 73.7 million shares of common stock at $21.00 per share.
On September 29, 2022, Piper Sandler downgraded the stock to Neutral based on work showing that "competition and misinformation pose growing risks to the company." On this news, Olaplex's stock price fell $1.33, or 12.2%, to close at $9.62 per share on September 29, 2022, thereby injuring investors.
More on The PennZone
- Habitat EJC Assembles National Team for Permanently Affordable Community
- Scott Cooper Miami Project Announces New Scholarship Winner: Aban Khan
- The Advanced Leadership Institute and Carnegie Mellon University Graduate the Inaugural Cohort of the National Executive Leadership Academy
- Utz Brands, Inc. Declares Quarterly Cash Dividend
- Incandescent Entertainment Announces New Film, "Portal in the Pines," starring Jamie Kennedy to Begin Filming This Month in Lousiana
Then, on October 18, 2022, Olaplex reduced its financial outlook for fiscal 2022, expecting net sales between $704 million and $711 million. The Company attributed the revised guidance to "a slowdown in sales momentum that it attributes to macro-economic pressures, increased competitive activity including discounting, and a moderation in new customer acquisition." Additionally, Olaplex announced that its Chief Operating Officer was stepping down from her post.
On this news, Olaplex's stock price fell $5.55, or 56.7%, to close at $4.24 per share on October 19, 2022, significantly below the IPO price.
The complaint filed in this class action alleges that Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company's business, operations, and prospects. Specifically, Defendants failed to disclose to investors that: (1) macroeconomic pressures and competition in the haircare market were more robust than the Company had represented to investors; (2) accordingly, the Company was unlikely to maintain its sales and revenue momentum; and (3) as a result, it was unlikely that the Company would be able to achieve the financial and operational growth projected in the Offering Documents; and (4) as a result, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis at all relevant times.
More on The PennZone
- Tella Firma Foundations Partners with Green Clean Solar to Increase Steel Recycling in the Renewable Energy Industry
- Feature film about President Trump's response to the pandemic and the 2020 election – streaming now
- Elevating the Workplace Experience through Innovative Technology Design
- The Society of Voice Arts and Sciences has joined with Audible for the Muhammad Ali Voice of Humanity Honor to be presented to Viola Davis
- INVESTIGATION ALERT: Berger Montague is Investigating Securities Fraud Claims on Behalf of Eagle Pharmaceuticals, Inc. (NASDAQ: EGRX) Investors
If you purchased Olaplex common stock, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Howard G. Smith, Esquire, of Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020, by telephone at (215) 638-4847, toll-free at (888) 638-4847, or by email to howardsmith@howardsmithlaw.com, or visit our website at www.howardsmithlaw.com.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
Contacts
Law Offices of Howard G. Smith
Howard G. Smith, Esquire
215-638-4847
888-638-4847
howardsmith@howardsmithlaw.com
www.howardsmithlaw.com
Filed Under: Business
0 Comments
Latest on The PennZone
- Real Estate Industry Veteran Celeste Starchild Promoted to President of InspectionGo
- The Five Pillars of Success Pillar One Strengths Outlined by Rosann Santos CPC
- Pitch Black Appoints New Chief People Officer
- Benjamin Ross Group, LLC Sells Commercial Cleaning Service Company, Montgomery County, PA
- Emmy Award Winning Journalist Joins Prominent Haddonfield Real Estate Agency
- Leading Tier 1 European Mobile Operator Signs New SafePath® Multiyear Contract with Smith Micro
- HARMONY BIOSCIENCES TO PRESENT RESULTS FROM BEHAVIORAL STUDY IN 22Q11.2 DELETION SYNDROME AT AMERICAN COLLEGE OF NEUROPSYCHOPHARMACOLOGY ANNUAL MEETING
- Founder Brings Inaugural Event To Braselton Georgia At Legendary Resort and Winery
- HBCUs Among Groups Heading to The Bahamas for Track & Field Competition in March 2024
- Noble World Foundation Proposes UN Security Council Reform to Foster Global Peace
- InventHelp Inventor Develops Privacy Tent for Personal Commodes (PND-5108)
- India Fest 2024 on Jan 27, 2024 at KY Expo Center
- Pennsylvania: Governor Shapiro Hosts Ceremonial Bill Signing for HB 735 with Insurance Commissioner Humphreys, Bipartisan Legislative Leaders at the Yardley Inn in Bucks County
- Transitions Healthcare, LLC Acquires The Shook Home & The Quarters at Shook in Chambersburg, PA
- InventHelp Inventor Develops Laundromat Cart Liner (PLB-268)
- Genuine Hospitality, LLC Adds the Hampton Inn - Columbia, MO to Growing Portfolio
- REA 'Peace of Mind on the Move' Study achieves Highly Commended recognition in the category Excellence in Coaching by ABP November 2023
- Revolutionizing FEC Chain Stores with Our Cutting-Edge Ordering& Warehousing System
- Aramark Receives Equality 100 Award from the Human Rights Campaign Foundation
- The Designery expands into Pennsylvania with a new location in Quakertown